Author/Creator: Aikawa, E - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Aikawa, E

1. Inhibition of novel lipoprotein(a) receptor major facilitator superfamily domain containing 5 (MFSD5) reduces development of aortic valve calcification. (10th June 2022)

Authors:: Bartoli-Leonard, F; Rogers, M; Zheng, K; Small, A; Asano, T; Kuraoka, S; Blaser, M; Natarajan, P; Yeang, C; Tsimikas, S; O'donnell, C; Aikawa, M; Singh, S; Stroes, E; Aikawa, E
Journal:: Cardiovascular research
Issue:: Volume 118(2022)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. P5090Sortilin is a key driver of fibrocalcific aortic valve disease. (28th August 2018)

Authors:: Schlotter, F; Goettsch, C; Rogers, M A; Hutcheson, J D; Blaser, M C; Goto, S; Lee, L H; Delaughter, D M; Merryman, W D; Seidman, J G; Jaffer, F A; Body, S C; Aikawa, M; Singh, S A; Aikawa, E
Journal:: European heart journal
Issue:: Volume 39(2018)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. P5457Lipoprotein(a) is associated with increased calcification and disease progression in aortic stenosis patients. (28th August 2018)

Authors:: Zheng, K H; Pawade, T A; Kroon, J; Hjortnaes, J; Jenkins, W S; Arsenault, B J; Rogers, M A; Aikawa, E; Newby, D E; Stroes, E S; Tsimikas, S; Boekholdt, S M; Dweck, M R
Journal:: European heart journal
Issue:: Volume 39(2018)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗